Xpeer course: Health outcomes of drugs-gut microbiota interactions

Synopsis of the course

• The contribution of the gut microbiota to food and drug metabolism and human immune system regulation is a recent discovery with potentially enormous clinical consequences.
• In recent years, it is becoming increasingly clear that chemical compounds present in drugs or their metabolites can impact microbial composition in the gut and impair their functional contributions to the host. On the other hand, the microbiome plays a clinically relevant role in drug disposition.
• Pharmacomicrobiomics seeks to understand how inter-individual variations in the microbiome shape drug efficacy and side effect profiles. Multiple bacterial species, genes, and enzymes have been implicated in the biotransformation of drugs.
• Anyway, drug–microbe interactions are still understudied in the clinical context, thus more research seeking to establish clinically-validated microbially-related parameters is the next horizon in this fascinating field of biomedical research.

Reference of this course on Xpeer: SBIO21GUA1

Who is professor Guarner ?

• Francisco Guarner Aguilar, MD, PhD, is a gastroenterologist and senior researcher at the Vall d’Hebron Research Institute.
• He is the author of more than 300 publications in international research journals, many of which are landmark contributions to the field of microbiota and health.
• In 2020, he was recognized as one of the most influential researchers in the decade of 2010-2020, receiving the Web of Science’s Highly Cited Researchers (Cross Field) distinction.
• He is a member of the Guidelines Committee of the World Gastroenterology Organisation, the Steering Committee of the International Human Microbiome Consortium, and past member of the Board of Directors on the International Scientific Association for Probiotics and Prebiotics.
• Conflicts of Interest Statement: Francisco Guarner receives research grants from Abbvie, Takeda and AB-Biotics, and honoraria or consultation fees from Instituto Danone, Sanofi, Biocodex, Actial, Menarini and Ordesa.

What is Xpeer?

Xpeer Medical Education is the first accredited medical education app in the market, with video microlearning engaging videos of just 5 minutes.

With a powerful algorithm to personalize the user experience and the contents as the most popular entertaining streaming platforms, it offers a brand new experience for the continuing education and professional development of the healthcare professionals.

Accredited by the European Union of Medical Specialists, it delivers high quality scientific medical education pieces. On Xpeer, you will find this curriculum on Microbiota and 500 hours of medical education in 2021 in your specialty, technologies and professional and personal skills.

Information on accreditation

The app Xpeer is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide official ECMEC credits recognized officially in 26 countries.

The credits for the users of the module will be 1 European CME credit (ECMEC®) for every hour (60 minutes of actual e-learning excluding introductions etc.) of use, provided that the users have completed a module and have passed the relevant assessment.